There are currently 15 active clinical trials seeking participants for Lung Neoplasms research studies. The states with the highest number of trials for Autism participants are California, Texas, Tennessee and Florida.
Circulating Tumor Cells (CTC) in Lung Cancer
Recruiting
The primary objective of this study is to establish circulating tumor cell (CTC) derived xenografts and assess the activity of novel DNA repair inhibitors as a function of DNA repair mutations detected in CTC samples (personalize DNA repair therapy).
Gender:
All
Ages:
18 years and above
Trial Updated:
09/11/2023
Locations: Indiana University Health Hospital, Indianapolis, Indiana +1 locations
Conditions: Lung Neoplasms
Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy
Recruiting
The purpose of this study is to determine the maximum dose that is safely tolerated of the experimental drug Rhenium Re 188 P2045. This will be done by first treating patients at relatively low doses of Rhenium Re 188 P2045, observing them closely to assure that there are no bad side effects, then increasing the dose when we are confident that it is safe to do so.
Gender:
All
Ages:
21 years and above
Trial Updated:
10/31/2022
Locations: Not set, Iowa City, Iowa +1 locations
Conditions: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell, Neoplasm Recurrence, Local
Near-Infrared Perfusion During Minimally Invasive Thoracic Surgery Download
Recruiting
This will be a prospective, (NSR), single-center feasibility study of the Olympus VE2 NIR Imaging System to assess perfusion using NIR during minimally invasive esophagectomy and pulmonary segmentectomy. The aims of the study are: 1. To utilize NIR intraoperative imaging with the Olympus VE2 NIR Imaging System to: i. Characterize gastric conduit perfusion during esophagectomy and, ii. Identify segmental anatomy during sublobar pulmonary resection (segmentectomy) after intraoperative, intravenou... Read More
Gender:
All
Ages:
All
Trial Updated:
04/20/2022
Locations: Massachusetts General Hospital, Boston, Massachusetts
Conditions: Lung Neoplasms, Esophageal Lesion